News

Newseria BIZNES13h
Vitalgen’s Gene Therapy Drug VGN-R09b for Primary Parkinson’s Disease Receives FDA Fast Track Designation
R09b, for the treatment of Primary Parkinson’s Disease (PD), has received Fast Track Designation (FTD) from the U.S. Food and ...
The Manila Times8h
The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
NFL super-agent Leigh Steinberg opens up about the brain trauma crisis in football and his mission to protect athletes ...
pharmaphorum1d
Bayer gains ground in two-fronted Parkinson's offensive
Bayer's cell therapy for Parkinson's disease is on the brink of a phase 3 trial, while its gene therapy has started phase 2 testing. Skip to main content Friday 27 June 2025 . BlueSky ...